Vulvovaginal Pyoderma Gangrenosum Secondary to Rituximab Therapy.

Journal of lower genital tract disease

PubMedID: 24769650

Dixit S, Selva-Nayagam P, Hamann I, Fischer G. Vulvovaginal Pyoderma Gangrenosum Secondary to Rituximab Therapy. J Low Genit Tract Dis. 2014;.
Rituximab is being used increasingly for the treatment of B-cell malignancies and nonmalignant conditions. Pyoderma gangrenosum is a rare neutrophilic dermatosis, which can be either idiopathic or associated with underlying systemic inflammatory conditions. We present a series of 4 patients who presented with ulcerative pyoderma gangrenosum in the vulvovaginal area after treatment with rituximab.